Clinical trials: Recurrent AL Amyloidosis
Recurrent AL Amyloidosis, Refractory AL Amyloidosis
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
This phase I/Ia trial finds the best dose and side effects of venetoclax given in combination with ixazomib citrate and dexamethasone in treating patients with light chain amyloidosis that has come back (relapsed) or does not…
- Trial name
- NCT04847453
- Testing
- Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Computed Tomography
- Where
- 16 sites in United States
- Volunteers
- 24 people
- Sponsor
- National Cancer Institute (NCI)